Form 4: HealthEquity Director Exercises Options, Sells Shares
Insider Transaction Report
HealthEquity Director Evelyn Dilsaver exercised stock options and subsequently sold a portion of the acquired shares.
Summary
- Evelyn S Dilsaver, a Director at HealthEquity, Inc. (HQY), reported transactions scheduled for September 5, 2025.
- Ms. Dilsaver exercised 15,000 stock options at a price of $21.27 per share.
- Concurrently, she disposed of 3,461 shares of common stock at a price of $93.3013 per share.
- Following these transactions, Ms. Dilsaver's direct beneficial ownership of common stock will be 48,208 shares.
- Remaining derivative holdings include 4,339 stock options exercisable at $50.41 and 4,012 stock options exercisable at $66.06.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive due to the director's profitable exercise of options, indicating value realization. The subsequent sale of a portion of shares is a common and generally neutral event for personal financial management.
Positives
- The exercise of stock options at a lower price ($21.27) and subsequent sale at a significantly higher price ($93.3013) indicates a profitable transaction for the director.
- The exercise of options demonstrates the director's engagement with their equity compensation plan.
Negatives
- The sale of 3,461 shares by a director, while common for tax or diversification purposes, represents a reduction in direct insider ownership.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
Insider transactions, such as option exercises and subsequent share sales, are routine events in publicly traded companies. They often reflect personal financial planning, tax obligations, or portfolio diversification strategies of executives and directors, rather than a direct commentary on the company's immediate operational outlook.
Stakeholder Impact
- Shareholders: The sale of shares by a director could be perceived as a minor negative, but the volume is relatively small and often part of a pre-planned trading arrangement (Rule 10b5-1(c)), mitigating significant concern.
Key Dates
| Date | Description |
|---|---|
| 02/01/2026 | Expiration date for 15,000 stock options exercised on 09/05/2025. |
| 02/01/2028 | Expiration date for 4,339 remaining stock options. |
| 02/01/2030 | Expiration date for 4,012 remaining stock options. |
| 09/05/2025 | Date of reported stock option exercise and common stock disposition. |
| 09/09/2025 | Date the Form 4 filing was signed by the attorney-in-fact. |
Keywords
HealthEquity, HQY, Insider Transaction, Form 4, Stock Options, Share Sale, Director, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.